Researchers at Yonsei University College of Medicine (YUCM) have found that SGLT-2 inhibitors, commonly prescribed to diabetes patients, are effective in reducing the symptoms of non-alcoholic steatohepatitis (NASH).Non-alcoholic fatty liver disease (NAFLD) occurs due to the accumulation of fat in t
Lundbeck is drawing the industry’s attention by saying it would begin a phase 2 clinical trial of an autoimmune disease candidate it licensed in (L/I) from Korean biotech Aprilbio.Through a conference call for the first half-year on Wednesday (local time), Lundbeck announced it plans to start the ph
MSD Korea has joined hands with Seventeen, a Korean idol group, to raise awareness of the importance of HPV (human papillomavirus) prevention.The company said Thursday that it has selected global influencer Seventeen as the ambassador for its HPV prevention campaign.The company produced a TV campaig
HK inno.N said that it has entered into an exclusive distribution and co-commercialization agreement with Roche Korea for the latter's Xofluza, a once-daily antiviral treatment for influenza.Under the agreement, HK inno.N will be responsible for the distribution of Xofluza for two years, and Roche K
Lotte Healthcare said on Wednesday that it signed a memorandum of understanding (MOU) with iMediSync, a digital mental health management platform company, to jointly develop healthcare models based on artificial intelligence (AI).Founded in 2012, iMediSync specializes in the measurement of brainwave
Celltrion said on Monday that its consolidated revenue for the second quarter of this year was 524 billion won ($393 million won) and operating income was 183 billion won, down 12.1 percent and 10.1 percent year-on-year, respectively. Net profit was down 18 percent to post 151 billion won. Celltrion
CG Bio, a Korean developer of spinal disorder and wound management solutions, said on Monday its Advanced LumFix Spinal Fixation System (Advanced LumFix), an implant and surgical device for spinal correction, has received 510(k) clearance from the U.S. FDA.With the approval, Advanced LumFix is expec
Handok has voluntarily withdrawn its IND (Investigational New Drug) application for a domestic phase 2/3 clinical trial of its biliary tract cancer treatment after failing to meet the Ministry of Food and Drug Safety (MFDS) requirements.The industry’s attention is now on its impact on the global cli
JW Pharmaceutical, which has been hitting new highs in share prices for 52 consecutive weeks, met the market’s expectations by posting a record performance in the second quarter.On Wednesday, JW Pharm released preliminary operating results for the second quarter in a public filing.On a standalone ba
Prestige Biopharma said on Friday that it signed a memorandum of understanding (MOU) with Imagion Biosystems, a U.S. imaging diagnostics company, to develop an early diagnosis platform for pancreatic cancer. Under the partnership, Prestige Biopharma will provide pancreatic adenocarcinoma up-regulate
MSD Korea has recently applied for expanding reimbursement for Keytruda (pembrolizumab) to cover all its 13 cancer indications with high unmet needs.Among indications newly requested for coverage are triple-negative breast, head and neck, and esophageal cancers, which are aggressive enough to threat
Just a few weeks after the official launch of Samsung Bioepis and Organon’s Humira (ingredient: adilumab) biosimilar, Hadlima, in the U.S. market, it is quickly gaining traction, after being added to two large U.S. insurers.This marks the fourth U.S. insurer to register the drug. Previously, Prime T
Children's cold medicines suspended due to quality control issues are back on the market after improvements.The Ministry of Food and Drug Safety said Thursday that it had lifted the suspension of manufacturing and sales of Dong-A Pharmaceutical's Champ Syrup and Daewon Pharmaceutical's Coldaewon Kid
Hugel said it recorded the largest second quarterly earnings in its history, thanks to strong sales from its botulinum toxin, fillers, and cosmetic lineup.The company's sales and operating profit for the second quarter was 81.6 billion won ($61.9 million) and 21.4 billion won, both up 28 percent com
BL Science, a subsidiary of BL Pharmtech, said on Thursday that it signed an agreement with Kumoh National Institute of Technology, a local university, to jointly develop a cancer diagnosis solution utilizing artificial intelligence (AI) in tissue and cellular pathology diagnosis.BL Science is a dia
For Korean pharmaceutical products to compete in overseas markets, the nation must urgently improve its drug pricing system by, for instance, assigning appropriate values to new drugs, experts said.They added that the industry must also raise the self-sufficiency rate of homegrown active pharmaceuti
Ildong Pharmaceutical said on Wednesday that it will separate its research and division (R&D) department and establish a subsidiary to boost profitability and R&D.Ildong Pharmaceutical will maintain a 100 percent stake in the new company as the parent company. The tentative name of the corporation i
Korea's healthcare industry is doubling efforts to support participants of the 25th World Scout Jamboree, although its organizers were heavily criticized for disorganization and unpreparedness.Most recently, Daewoong Co. said that it has fully opened its human resource development (HRD) training cen
EONE-Diagnomics Genome Center (EDGC) said on Thursday that it formed a task force for the Cancer Moonshot project and is in discussions with the CancerX team about joining as a member with its companion diagnostic (CDx) liquid biopsy, ONCOCATCH.EONE-Diagnomics Genome Center is a joint venture betwee
Palatin Technologies, a U.S. pharmaceutical company, said that Kwangdong Pharmaceutical, its Korean partner, has nearly completed a phase 3 clinical trial in Korea for Vyleesi (ingredient: bremelanotide), a hypoactive sexual desire disorder (HSDD) treatment for women. Kwangdong licensed in Vyleesi i